Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Telomeres are specialized nucleoprotein complexes, localized at the physical ends of chromosomes, that contribute to the maintenance of genome stability. One of the features of
chronic myeloid leukemia
(
CML
) cells is a reduction in telomere length which may result in increased genomic instability and progression of the disease. Aberrant telomere maintenance in
CML
is not fully understood and other mechanisms such as the alternative lengthening of telomeres (ALT) are involved. In this work, we employed five
BCR-ABL1
-positive cell lines, namely K562, KU-812, LAMA-84,
MEG
-A2, and MOLM-1, commonly used in the laboratories to study the link between mutation, copy number, and expression of telomere maintenance genes with the expression, copy number, and activity of
BCR-ABL1
. Our results demonstrated that the copy number and expression of
BCR-ABL1
are crucial for telomere lengthening. We observed a correlation between
BCR-ABL1
expression and telomere length as well as shelterins upregulation. Next-generation sequencing revealed pathogenic variants and copy number alterations in major tumor suppressors, such as TP53 and CDKN2A, but not in telomere-associated genes. Taken together, we showed that
BCR-ABL1
kinase expression and activity play a crucial role in the maintenance of telomeres in
CML
cell lines. Our results may help to validate and properly interpret results obtained by many laboratories employing these in vitro models of
CML
.
...
PMID:Differential Regulation of Telomeric Complex by
BCR-ABL1
Kinase in Human Cellular Models of Chronic Myeloid Leukemia-From Single Cell Analysis to Next-Generation Sequencing. 3300 26
<< Previous
1
2
3